Skip to content
biotechnology hero image
biotechnology hero image

Biotechnology

Our team regularly advises clients developing biotech products in areas including biotechnology derived proteins (such as insulin), immunologicals (such as vaccines and allergens), blood or plasma derived products, and engineered tissues.

Our team benefits from having several members of the group who have completed degrees in subjects including molecular biology, biochemistry and genetics. This knowledge enables us to quickly grasp technical concepts and provide nuanced and tailored advice.

We closely follow new developments and emerging trends in the biotech market. For example, we have been following the emerging regulatory pathways for biosimilars and advising clients on appropriate strategies.

We have worked with many well-known companies on their biological products, including Pfizer, Novartis, Regeneron, Amgen and Roche.

News & insights

Publications: 29 JULY 2020

A hard pill to swallow: Belgian Court of Cassation provides clarity on patient informed consent

Setting the stage Since long, discussions in Belgium have been ongoing as to who needs to prove that a patient was sufficiently informed about his/her treatment and its potential complications. With…

Read more
A group of modern high-rise offices and skyscrapers

News: 20 JULY 2020

Advising GSK on its strategic collaboration with CureVac

An A&O team comprising UK, German, U.S. and Dutch lawyers is advising GlaxoSmithKline (GSK) on its strategic collaboration with German biotech company CureVac for the research, development and…

Read more
Bird's eye view of a major intersection and suspension bridge at night

News: 10 JULY 2020

Allen & Overy advises on Immunotech Biopharm’s global offering and listing on the Hong Kong Stock Exchange

Allen & Overy has advised the joint sponsors on the global offering and listing of shares of Immunotech Biopharm Ltd (Immunotech Biopharm) on the Hong Kong Stock Exchange under Chapter 18A of the…

Read more
Allen & Overy assists Eurofins in recent equity and debt capital market transactions

News: 22 MAY 2020

A&O assists Eurofins in recent equity and debt capital market transactions

Allen & Overy has advised Eurofins Scientific (Eurofins) on a successful fundraising through the issuance of new shares and a bond issuance. 

Read more

Download our sector brochure

Life sciences A&O red molecules

An insight in to our Life Science and Healthcare sector 2020

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.